PURE Bioscience, Inc.
PURE
$0.08
$0.00-4.58%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 198.00K | 434.00K | 334.00K | 540.00K | 202.00K |
| Total Receivables | 252.00K | 389.00K | 474.00K | 287.00K | 180.00K |
| Inventory | 244.00K | 237.00K | 141.00K | 131.00K | 75.00K |
| Prepaid Expenses | 10.00K | 41.00K | 23.00K | 13.00K | 30.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 75.00K | 75.00K | 75.00K | 75.00K | 75.00K |
| Total Current Assets | 779.00K | 1.18M | 1.05M | 1.05M | 562.00K |
|
|
|||||
| Total Current Assets | 779.00K | 1.18M | 1.05M | 1.05M | 562.00K |
| Net Property, Plant & Equipment | 9.00K | 10.00K | 11.00K | 11.00K | 12.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 788.00K | 1.19M | 1.06M | 1.06M | 574.00K |
|
|
|||||
| Total Accounts Payable | 767.00K | 879.00K | 784.00K | 799.00K | 700.00K |
| Total Accrued Expenses | 149.00K | 176.00K | 154.00K | 173.00K | 166.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.14M | 2.10M | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.06M | 3.16M | 938.00K | 972.00K | 866.00K |
|
|
|||||
| Total Current Liabilities | 3.06M | 3.16M | 938.00K | 972.00K | 866.00K |
| Long-Term Debt | 4.01M | 3.57M | 5.24M | 4.90M | 3.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.06M | 6.73M | 6.17M | 5.87M | 4.84M |
|
|
|||||
| Common Stock & APIC | 133.97M | 133.91M | 133.88M | 133.85M | 133.82M |
| Retained Earnings | -140.24M | -139.46M | -138.99M | -138.66M | -138.08M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -6.27M | -5.55M | -5.12M | -4.81M | -4.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.27M | -5.55M | -5.12M | -4.81M | -4.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.27M | -5.55M | -5.12M | -4.81M | -4.27M |
|
|
|||||